Nexthera Capital’s ANI Pharmaceuticals ANIP Stock Holding History

Nexthera Capital’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-41,905	Closed	-$2.7M	–	42
2017 Q4	$2.7M	Buy	+41,905	New	+$2.61M	0.5%	35

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Nexthera Capital's ANIP Position: Q1 2018 in Review

Nexthera Capital sold out of ANI Pharmaceuticals (ANIP) in Q1 2018, closing a stake of 41,905 shares — an estimated $2.7M sold.

Nexthera Capital first reported a position in ANIP in Q4 2017 and held it in 1 quarter. The position peaked at $2.7M in Q4 2017. 175 funds tracked by Wall St. Rank hold ANIP as of Q1 2018.

Nexthera Capital reported no remaining ANI Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
Nexthera Capital sold 41,905 ANI Pharmaceuticals shares in Q1 2018, an estimated $2.7M.
Nexthera Capital first reported a position in ANI Pharmaceuticals in Q4 2017 and held it in 1 quarter.
Nexthera Capital's ANI Pharmaceuticals position peaked at $2.7M in Q4 2017.
175 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2018.

Based on Nexthera Capital's 13F filing for Q1 2018, filed 15 May 2018.